Prevention and treatment of hepatic encephalopathy: Focusing on gut microbiota

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 46

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

635

HTML

7474

Figures (1-1)

341

Tables (1-1)

244

Sum=8694

Dec 14, 2012 (publication date) through Dec 19, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Gastroenterol. Dec 14, 2012; 18(46): 6693-6700
Published online Dec 14, 2012. doi: 10.3748/wjg.v18.i46.6693

Figure 1 Pathophysiology of hepatic encephalopathy in liver cirrhosis. GABA: γ-aminobutyric acid.

Citation: Garcovich M, Zocco MA, Roccarina D, Ponziani FR, Gasbarrini A. Prevention and treatment of hepatic encephalopathy: Focusing on gut microbiota. World J Gastroenterol 2012; 18(46): 6693-6700
URL: https://www.wjgnet.com/1007-9327/full/v18/i46/6693.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i46.6693